The largest database of trusted experimental protocols

El transfection reagent

Manufactured by Transgene
Sourced in China

EL Transfection Reagent is a proprietary lipid-based transfection agent developed by Transgene. It is designed to facilitate the efficient delivery of genetic material into a variety of cell types for research and experimental applications.

Automatically generated - may contain errors

6 protocols using el transfection reagent

1

Downregulation of ASH1L in PC3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC3 cells were plated at a 6-well plate with 3.5 × 105 cells per well. After overnight culture, 250- pmol siNC or siASH1L#1 were transfected with 10 μl of the EL transfection reagent (TransGen Biotech, catalog no. FT201) per well as dictated by the protocol. The cells were collected at 48 h; 10% of the cells were treated with the RNAiso Plus reagent, and the remaining cells were quickly frozen with liquid nitrogen. The knockdown efficiency of the ASH1L gene was confirmed by qRT-PCR after mRNA extraction. The frozen samples were mailed to BGI Bioinformatics Corporation (Wuhan, China) with the project number: F21FTSNCKF3033_HONgbclN. The RNA preparation, library construction, and sequencing using the DNBSEQ platform were performed at BGI. RNA sample quality was examined by Bioanalyzer (Agilent 2100). After getting clean reads, Bowtie2 (version: v2.2.5) was used to map the clean reads to the reference gene sequence (transcriptome), and the gene expression level of each sample was calculated with RSEM (v1.2.8). The DEseq2 method was used for differential gene detection, and according to results of the differential gene detection, the R Package pheatmap was used to perform hierarchical analysis on the union set differential genes. The data were analyzed using the BGI Dr. Tom multi-omics integration analysis website (https://biosys.bgi.com/#/report/login).
+ Open protocol
+ Expand
2

siRNA Knockdown of RNF11 and ZMYND11 in DF-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNAs (double-stranded RNA oligonucleotides) (Genepharma, China) were used to knockdown the expressions of RNF11 and ZMYND11 in DF-1 cells and the sequences were shown in Table 1. siRNA duplexes were transfected into DF-1 cells at a final concentration of 50 nM using EL Transfection Reagent (Transgen Biotech, China). The interference efficiency was detected by qRT-PCR and Western blot as described below.
+ Open protocol
+ Expand
3

Dual-Luciferase Assay for miRNA Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
DF-1 cells cultured on 12-well plate were co-transfected with indicated plasmids (250 ng) and miRNA oligonucleotides (100 nM) using EL Transfection Reagent (Transgen Biotech, China). After 24 h, luciferase activities were determined using the Dual-GLO® Luciferase Assay System Kit (Promega, USA) following the protocol supplied. The relative luciferase activities were calculated by dividing Renilla luciferase values by internal control firefly luciferase values.
+ Open protocol
+ Expand
4

Investigating lncRNA in Colon Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colon cancer cell line SW620 was obtained from Wuhan Procell Life Science & Technology Co., Ltd, and hBD-1 was purchased from Sino Biological, Inc. (China). The total RNA extraction kit was purchased from TIANGEN Biotech (Beijing) Co., Ltd. The Trizol kit was acquired from Takara Bio Inc. (Japan), and chloroform was purchased from Beijing Dingguo Changsheng Biotechnology Co., Ltd. EL Transfection Reagent was purchased from TransGen Biotech Co., Ltd (Beijing). Additionally, si-lncRNA (Suzhou Gemma Biotechnology Co., Ltd.), BCA kit (Shanghai Epizyme Biotech Co., Ltd.), and Western blot reagents (Beyotime Biotech. Inc., Shanghai) were used. The antibody was purchased from Cell Signaling Technology Inc. (United States).
+ Open protocol
+ Expand
5

Subcellular Localization of GFP-tagged Mx Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monolayer GEFs, BHK21, and HEK 293T cells were seeded on coverslips overnight, and were then transfected with a test group of pEGFP-C1-Mx and pEGFP-C1-NLS/Mx (pEGFP-C1 and pEGFP-C1-SV40 as controls, respectively) by using the EL transfection reagent (TransGen, Beijing, China) according to the manufacturer’s directions. After 24 h of transfection, the micro coverslips were directly fixed in 4% paraformaldehyde, and were stained with 4′,6-diamidine-2′-phenylindole dihydrochloride (DAPI) to determine the location of pEGFP-C1-Mx or pEGFP-C1-NLS/Mx. For pcDNA3.1(+) carrying His-tagged goMx or its variants, BHK21 cells were transfected with indicated expression plasmids. At 24 h post-transfection, cells were fixed, permeated, and stained with a mouse His-tagged mAb (as mentioned above) at a 1:500 dilution, and were then incubated with the Alexa Fluor PE-conjugated fluorescent goat-anti-mouse secondary antibodies (Life Technologies, Carlsbad, CA, USA).
+ Open protocol
+ Expand
6

Overexpression and Inhibition of gga-miR-19b-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gga-miR-19b-3p mimic was chemically modified double-stranded oligonucleotides for overexpression of gga-miR-19b-3p and gga-miR-19b-3p inhibitor was single-stranded oligonucleotides for inhibition of gga-miR-19b-3p. All RNA oligonucleotides were designed and synthesized by GenePharma, China. For miRNA transfection, DF-1 cells were transfected with gga-miR-19b-3p mimic and inhibitor and mimic negative control (mimic-NC) and inhibitor negative control (inh-NC) at a final concentration of 100 nM using EL Transfection Reagent (Transgen Biotech, China) following the manufacturer’s instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!